316141-37-4

Basic information

• Product Name: 1-Pyrrolidinecarboxylic acid, 2-ethynyl-, 1,1-dimethylethyl ester
• Synonyms: 1-Pyrrolidinecarboxylic acid, 2-ethynyl-, 1,1-dimethylethyl ester;tert-butyl 2-ethynylpyrrolidine-1-carboxylate;1-Boc-2-Ethynylpyrrolidine;(R)-N-tert-Butoxycarbonyl-2-ethynylpyrrolidine
• CAS NO: 316141-37-4
• Molecular Formula: C₁₁H₁₇NO₂
• Molecular Weight: 195.26
• Mol File: 316141-37-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 249℃
• Flash Point: 104℃
• Appearance: /
• Density: 1.04
• Vapor Pressure: 0.023mmHg at 25°C
• Refractive Index: 1.492
• Storage Temp.: 2-8°C
• PKA: -3.16±0.40(Predicted)
• CAS DataBase Reference: 1-Pyrrolidinecarboxylic acid, 2-ethynyl-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pyrrolidinecarboxylic acid, 2-ethynyl-, 1,1-dimethylethyl ester(316141-37-4)
• EPA Substance Registry System: 1-Pyrrolidinecarboxylic acid, 2-ethynyl-, 1,1-dimethylethyl ester(316141-37-4)

Safety Data

• Hazardous Substances Data: 316141-37-4(Hazardous Substances Data)

Usage

General Description

1-Pyrrolidinecarboxylic acid, 2-ethynyl-, 1,1-dimethylethyl ester is a chemical compound that falls under the category of Pyrrolidines, or substituted Pyrrolidines, which are saturated organic compounds that contain the pyrrolidine ring - a five-member ring with one nitrogen atom and four carbon atoms. The compound's molecular formula is C9H15NO2, and it is characterized by its ester and carboxylic functional groups. This chemical may be used in various scientific applications such as research and development initiatives, where its properties can have particular uses. It is essential to handle and store the chemical properly due to its potentially reactive nature.

InChI:InChI=1/C11H17NO2/c1-5-9-7-6-8-12(9)10(13)14-11(2,3)4/h1,9H,6-8H2,2-4H3

Upstream product

• 90965-06-3 dimethyl 1-(1-diazo-2-oxopropyl)phosphonate 
• 59378-82-4 N-(tert-butoxycarbonyl)pyrrolidine-2-carboxaldehyde 

Downstream Products

• 1411982-78-9 methyl 7-[2-((Z)-3-diethylaminoprop-1-enyl)-4-fluorobenzenesulfonylamino]-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoline-6-carboxylate 
• 1411983-00-0 methyl 7-(2-bromo-4-fluorobenzenesulfonylamino)-1,2,3,3a,4,5-hexahydro-pyrrolo[1,2-a]quinoline-6-carboxylate 
• 1411983-03-3 methyl 3-bromo-6-(2,2-dimethylpropionylamino)-2-(2-pyrrolidin-2-yl-ethyl)-benzoate 
• 1411983-04-4 tert butyl 2-{2-[6-bromo-3-(2,2-dimethylpropionylamino)-2-methoxycarbonyl-phenyl]-ethyl}-pyrrolidine-1-carboxylate 
• 1411983-05-5 tert-butyl 2-{2-[3-(2,2-dimethylpropionylamino)-2-methoxycarbonylphenyl]-ethyl}-pyrrolidine-1-carboxylate 
• 1411983-06-6 tert-butyl 2-[3-(2,2-dimethylpropionylamino)-2-methoxycarbonylphenyl-ethynyl]-pyrrolidine-1-carboxylate 
• 1411982-70-1 7-[2-((Z)-3-diethylaminoprop-1-enyl)-4-fluorobenzenesulfonylamino]-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoline-6-carboxylic acid 

Relevant articles and documents

QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITOR, COMPOSITIONS, METHODS OF MAKING THEM AND THEIR USE

The present disclosure relates to new compounds or pharmaceutically acceptable salts or stereoisomers thereof of formula I as inhibitors of receptor tyrosine kinases (RTK), in particular extracellular mutants of ErbB-receptors. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the treatment of cancer in mammals (e.g. humans).

MACROCYCLIC SERINE PROTEASE INHIBITORS

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, pharmaceutical compositions comprising such compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.